论文部分内容阅读
以泰素单药治疗初治的转移性黑色素瘤有效率为16％（Wierniketal．MonogrNailCancerlust15：185－187，1993）。作者开始探索其作为二线药物治疗有皮肤和服葡萄膜转移的黑色素瘤病人的疗效。全部有皮肤黑色素瘤的病人以前均用过Dartmouth方案（BC－NU／DTIC／Cisplatin／TAM）
The effective rate of metastatic melanoma treated with paclitaxel monotherapy was 16% (Wierniketal. Monogr Nail Cancer lust 15:185-187, 1993). The authors began to explore the efficacy of its second-line treatment of melanoma patients with skin and uveal metastases. All patients with cutaneous melanoma have previously used the Dartmouth protocol (BC-NU/DTIC/Cisplatin/TAM)